Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone versus dexmedetomidine in caudal neuroplasty for chronic low back pain
IRCT20111102007984N28Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in chronic low back pain (CLBP) and lumbosacral radiculopathy comparing Triamcinolone + ropivacaine with Dexmedetomidine + ropivacaine (2 arms). Primary endpoint: Pain score. Started Sep 2017; status: completed.
02
Drugs
triamcinolonedexmedetomidineropivacaine
03
Conditions
chronic low back pain (CLBP)lumbosacral radiculopathy
Beyond the preview
Go deeper on IRCT20111102007984N28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20111102007984N28.